Robin A Lacour, Molly S Daniels, Shannon N Westin, Larissa A Meyer, Catherine C Burke, Kimberly A Burns, Shiney Kurian, Nicki F Webb, Terri B Pustilnik, Karen H Lu. Gynecol Oncol 2008
Times Cited: 50
Times Cited: 50
Times Cited
Times Co-cited
Similarity
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
Tuya Pal, Jenny Permuth-Wey, Judith A Betts, Jeffrey P Krischer, James Fiorica, Hector Arango, James LaPolla, Mitchell Hoffman, Martin A Martino, Katie Wakeley,[...]. Cancer 2005
Tuya Pal, Jenny Permuth-Wey, Judith A Betts, Jeffrey P Krischer, James Fiorica, Hector Arango, James LaPolla, Mitchell Hoffman, Martin A Martino, Katie Wakeley,[...]. Cancer 2005
30
BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.
Kathryn Alsop, Sian Fereday, Cliff Meldrum, Anna deFazio, Catherine Emmanuel, Joshy George, Alexander Dobrovic, Michael J Birrer, Penelope M Webb, Colin Stewart,[...]. J Clin Oncol 2012
Kathryn Alsop, Sian Fereday, Cliff Meldrum, Anna deFazio, Catherine Emmanuel, Joshy George, Alexander Dobrovic, Michael J Birrer, Penelope M Webb, Colin Stewart,[...]. J Clin Oncol 2012
28
Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.
H A Risch, J R McLaughlin, D E Cole, B Rosen, L Bradley, E Kwan, E Jack, D J Vesprini, G Kuperstein, J L Abrahamson,[...]. Am J Hum Genet 2001
H A Risch, J R McLaughlin, D E Cole, B Rosen, L Bradley, E Kwan, E Jack, D J Vesprini, G Kuperstein, J L Abrahamson,[...]. Am J Hum Genet 2001
22
Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities.
Larissa A Meyer, Meaghan E Anderson, Robin A Lacour, Anuj Suri, Molly S Daniels, Diana L Urbauer, Graciela M Nogueras-Gonzalez, Kathleen M Schmeler, David M Gershenson, Karen H Lu. Obstet Gynecol 2010
Larissa A Meyer, Meaghan E Anderson, Robin A Lacour, Anuj Suri, Molly S Daniels, Diana L Urbauer, Graciela M Nogueras-Gonzalez, Kathleen M Schmeler, David M Gershenson, Karen H Lu. Obstet Gynecol 2010
22
There is no decision to make: experiences and attitudes toward treatment-focused genetic testing among women diagnosed with ovarian cancer.
B Meiser, M Gleeson, N Kasparian, K Barlow-Stewart, M Ryan, K Watts, D Menon, G Mitchell, K Tucker. Gynecol Oncol 2012
B Meiser, M Gleeson, N Kasparian, K Barlow-Stewart, M Ryan, K Watts, D Menon, G Mitchell, K Tucker. Gynecol Oncol 2012
35
Keeping it simple: genetics referrals for all invasive serous ovarian cancers.
R Demsky, J McCuaig, M Maganti, K J Murphy, B Rosen, S R Armel. Gynecol Oncol 2013
R Demsky, J McCuaig, M Maganti, K J Murphy, B Rosen, S R Armel. Gynecol Oncol 2013
29
Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.
Harvey A Risch, John R McLaughlin, David E C Cole, Barry Rosen, Linda Bradley, Isabel Fan, James Tang, Song Li, Shiyu Zhang, Patricia A Shaw,[...]. J Natl Cancer Inst 2006
Harvey A Risch, John R McLaughlin, David E C Cole, Barry Rosen, Linda Bradley, Isabel Fan, James Tang, Song Li, Shiyu Zhang, Patricia A Shaw,[...]. J Natl Cancer Inst 2006
20
Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer.
Shiyu Zhang, Robert Royer, Song Li, John R McLaughlin, Barry Rosen, Harvey A Risch, Isabel Fan, Linda Bradley, Patricia A Shaw, Steven A Narod. Gynecol Oncol 2011
Shiyu Zhang, Robert Royer, Song Li, John R McLaughlin, Barry Rosen, Harvey A Risch, Isabel Fan, Linda Bradley, Patricia A Shaw, Steven A Narod. Gynecol Oncol 2011
18
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
16
Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
Johnathan M Lancaster, C Bethan Powell, Noah D Kauff, Ilana Cass, Lee-May Chen, Karen H Lu, David G Mutch, Andrew Berchuck, Beth Y Karlan, Thomas J Herzog. Gynecol Oncol 2007
Johnathan M Lancaster, C Bethan Powell, Noah D Kauff, Ilana Cass, Lee-May Chen, Karen H Lu, David G Mutch, Andrew Berchuck, Beth Y Karlan, Thomas J Herzog. Gynecol Oncol 2007
14
Timing of BRCA1/BRCA2 genetic testing in women with ovarian cancer.
Molly S Daniels, Diana L Urbauer, Jennifer L Stanley, Kristin G Johnson, Karen H Lu. Genet Med 2009
Molly S Daniels, Diana L Urbauer, Jennifer L Stanley, Kristin G Johnson, Karen H Lu. Genet Med 2009
46
Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based study.
Kelly A Metcalfe, Isabel Fan, John McLaughlin, Harvey A Risch, Barry Rosen, Joan Murphy, Linda Bradley, Susan Armel, Ping Sun, Steven A Narod. Gynecol Oncol 2009
Kelly A Metcalfe, Isabel Fan, John McLaughlin, Harvey A Risch, Barry Rosen, Joan Murphy, Linda Bradley, Susan Armel, Ping Sun, Steven A Narod. Gynecol Oncol 2009
15
Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer.
Jonathan Ledermann, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Gordon Rustin, Clare Scott, Werner Meier, Ronnie Shapira-Frommer, Tamar Safra,[...]. N Engl J Med 2012
Jonathan Ledermann, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Gordon Rustin, Clare Scott, Werner Meier, Ronnie Shapira-Frommer, Tamar Safra,[...]. N Engl J Med 2012
14
Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.
Johnathan M Lancaster, C Bethan Powell, Lee-May Chen, Debra L Richardson. Gynecol Oncol 2015
Johnathan M Lancaster, C Bethan Powell, Lee-May Chen, Debra L Richardson. Gynecol Oncol 2015
14
BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer.
Michael J Hall, Julia E Reid, Lynn A Burbidge, Dmitry Pruss, Amie M Deffenbaugh, Cynthia Frye, Richard J Wenstrup, Brian E Ward, Thomas A Scholl, Walter W Noll. Cancer 2009
Michael J Hall, Julia E Reid, Lynn A Burbidge, Dmitry Pruss, Amie M Deffenbaugh, Cynthia Frye, Richard J Wenstrup, Brian E Ward, Thomas A Scholl, Walter W Noll. Cancer 2009
12
Prevalence of BRCA mutations and founder effect in high-risk Hispanic families.
Jeffrey N Weitzel, Veronica Lagos, Kathleen R Blazer, Rebecca Nelson, Charité Ricker, Josef Herzog, Colleen McGuire, Susan Neuhausen. Cancer Epidemiol Biomarkers Prev 2005
Jeffrey N Weitzel, Veronica Lagos, Kathleen R Blazer, Rebecca Nelson, Charité Ricker, Josef Herzog, Colleen McGuire, Susan Neuhausen. Cancer Epidemiol Biomarkers Prev 2005
12
Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
Katrina Armstrong, Ellyn Micco, Amy Carney, Jill Stopfer, Mary Putt. JAMA 2005
Katrina Armstrong, Ellyn Micco, Amy Carney, Jill Stopfer, Mary Putt. JAMA 2005
12
12
The impact of acculturation on awareness of genetic testing for increased cancer risk among Hispanics in the year 2000 National Health Interview Survey.
Susan T Vadaparampil, Louise Wideroff, Nancy Breen, Edward Trapido. Cancer Epidemiol Biomarkers Prev 2006
Susan T Vadaparampil, Louise Wideroff, Nancy Breen, Edward Trapido. Cancer Epidemiol Biomarkers Prev 2006
12
Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.
Peter C Fong, David S Boss, Timothy A Yap, Andrew Tutt, Peijun Wu, Marja Mergui-Roelvink, Peter Mortimer, Helen Swaisland, Alan Lau, Mark J O'Connor,[...]. N Engl J Med 2009
Peter C Fong, David S Boss, Timothy A Yap, Andrew Tutt, Peijun Wu, Marja Mergui-Roelvink, Peter Mortimer, Helen Swaisland, Alan Lau, Mark J O'Connor,[...]. N Engl J Med 2009
12
ACOG Practice Bulletin No. 103: Hereditary breast and ovarian cancer syndrome.
. Obstet Gynecol 2009
. Obstet Gynecol 2009
12
Preventing future cancers by testing women with ovarian cancer for BRCA mutations.
Janice S Kwon, Molly S Daniels, Charlotte C Sun, Karen H Lu. J Clin Oncol 2010
Janice S Kwon, Molly S Daniels, Charlotte C Sun, Karen H Lu. J Clin Oncol 2010
12
Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval.
Peter C Fong, Timothy A Yap, David S Boss, Craig P Carden, Marja Mergui-Roelvink, Charlie Gourley, Jacques De Greve, Jan Lubinski, Susan Shanley, Christina Messiou,[...]. J Clin Oncol 2010
Peter C Fong, Timothy A Yap, David S Boss, Craig P Carden, Marja Mergui-Roelvink, Charlie Gourley, Jacques De Greve, Jan Lubinski, Susan Shanley, Christina Messiou,[...]. J Clin Oncol 2010
12
Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy.
Kasmintan A Schrader, Jane Hurlburt, Steve E Kalloger, Samantha Hansford, Sean Young, David G Huntsman, C Blake Gilks, Jessica N McAlpine. Obstet Gynecol 2012
Kasmintan A Schrader, Jane Hurlburt, Steve E Kalloger, Samantha Hansford, Sean Young, David G Huntsman, C Blake Gilks, Jessica N McAlpine. Obstet Gynecol 2012
12
Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups.
Esther M John, Alexander Miron, Gail Gong, Amanda I Phipps, Anna Felberg, Frederick P Li, Dee W West, Alice S Whittemore. JAMA 2007
Esther M John, Alexander Miron, Gail Gong, Amanda I Phipps, Anna Felberg, Frederick P Li, Dee W West, Alice S Whittemore. JAMA 2007
10
Identification of germline 185delAG BRCA1 mutations in non-Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado.
Lisa G Mullineaux, Teresa M Castellano, Jeffrey Shaw, Lisen Axell, Marie E Wood, Sami Diab, Catherine Klein, Mark Sitarik, Amie M Deffenbaugh, Sharon L Graw. Cancer 2003
Lisa G Mullineaux, Teresa M Castellano, Jeffrey Shaw, Lisen Axell, Marie E Wood, Sami Diab, Catherine Klein, Mark Sitarik, Amie M Deffenbaugh, Sharon L Graw. Cancer 2003
11
Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force.
Heidi D Nelson, Laurie Hoyt Huffman, Rongwei Fu, Emily L Harris. Ann Intern Med 2005
Heidi D Nelson, Laurie Hoyt Huffman, Rongwei Fu, Emily L Harris. Ann Intern Med 2005
10
Interest, awareness, and perceptions of genetic testing among Hispanic family members of breast cancer survivors.
Amelie G Ramirez, Fabiola E Aparicio-Ting, Sandra San Miguel de Majors, Alexander R Miller. Ethn Dis 2006
Amelie G Ramirez, Fabiola E Aparicio-Ting, Sandra San Miguel de Majors, Alexander R Miller. Ethn Dis 2006
14
Perceived disadvantages and concerns about abuses of genetic testing for cancer risk: differences across African American, Latina and Caucasian women.
Hayley S Thompson, Heiddis B Valdimarsdottir, Lina Jandorf, William Redd. Patient Educ Couns 2003
Hayley S Thompson, Heiddis B Valdimarsdottir, Lina Jandorf, William Redd. Patient Educ Couns 2003
10
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.
M William Audeh, James Carmichael, Richard T Penson, Michael Friedlander, Bethan Powell, Katherine M Bell-McGuinn, Clare Scott, Jeffrey N Weitzel, Ana Oaknin, Niklas Loman,[...]. Lancet 2010
M William Audeh, James Carmichael, Richard T Penson, Michael Friedlander, Bethan Powell, Katherine M Bell-McGuinn, Clare Scott, Jeffrey N Weitzel, Ana Oaknin, Niklas Loman,[...]. Lancet 2010
10
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
10
Knowledge, attitudes, and interest in breast-ovarian cancer gene testing: a survey of a large African-American kindred with a BRCA1 mutation.
A Y Kinney, R T Croyle, W N Dudley, C A Bailey, M K Pelias, S L Neuhausen. Prev Med 2001
A Y Kinney, R T Croyle, W N Dudley, C A Bailey, M K Pelias, S L Neuhausen. Prev Med 2001
10
Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer.
Angela Chetrit, Galit Hirsh-Yechezkel, Yehuda Ben-David, Flora Lubin, Eitan Friedman, Siegal Sadetzki. J Clin Oncol 2008
Angela Chetrit, Galit Hirsh-Yechezkel, Yehuda Ben-David, Flora Lubin, Eitan Friedman, Siegal Sadetzki. J Clin Oncol 2008
10
Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40.
A Ardern-Jones, R Kenen, R Eeles. Eur J Cancer Care (Engl) 2005
A Ardern-Jones, R Kenen, R Eeles. Eur J Cancer Care (Engl) 2005
10
Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling?
C Bethan Powell, Ramey Littell, Elizabeth Hoodfar, Fiona Sinclair, Alice Pressman. Int J Gynecol Cancer 2013
C Bethan Powell, Ramey Littell, Elizabeth Hoodfar, Fiona Sinclair, Alice Pressman. Int J Gynecol Cancer 2013
12
Genetic risk assessment for women with epithelial ovarian cancer: referral patterns and outcomes in a university gynecologic oncology clinic.
Sue V Petzel, Rachel Isaksson Vogel, Tracy Bensend, Anna Leininger, Peter A Argenta, Melissa A Geller. J Genet Couns 2013
Sue V Petzel, Rachel Isaksson Vogel, Tracy Bensend, Anna Leininger, Peter A Argenta, Melissa A Geller. J Genet Couns 2013
17
Evidence for common ancestral origin of a recurring BRCA1 genomic rearrangement identified in high-risk Hispanic families.
Jeffrey N Weitzel, Veronica I Lagos, Josef S Herzog, Thaddeus Judkins, Brant Hendrickson, Jason S Ho, Charité N Ricker, Katrina J Lowstuter, Kathleen R Blazer, Gail Tomlinson,[...]. Cancer Epidemiol Biomarkers Prev 2007
Jeffrey N Weitzel, Veronica I Lagos, Josef S Herzog, Thaddeus Judkins, Brant Hendrickson, Jason S Ho, Charité N Ricker, Katrina J Lowstuter, Kathleen R Blazer, Gail Tomlinson,[...]. Cancer Epidemiol Biomarkers Prev 2007
8
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
8
Awareness of genetic testing for cancer among United States Hispanics: the role of acculturation.
Julia E Heck, Rebeca Franco, Janine M Jurkowski, Sherri Sheinfeld Gorin. Community Genet 2008
Julia E Heck, Rebeca Franco, Janine M Jurkowski, Sherri Sheinfeld Gorin. Community Genet 2008
15
Acculturation and familiarity with, attitudes towards and beliefs about genetic testing for cancer risk within Latinas in East Harlem, New York City.
Katarina M Sussner, Hayley S Thompson, Heiddis B Valdimarsdottir, William H Redd, Lina Jandorf. J Genet Couns 2009
Katarina M Sussner, Hayley S Thompson, Heiddis B Valdimarsdottir, William H Redd, Lina Jandorf. J Genet Couns 2009
11
Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers.
Timothy R Rebbeck, Noah D Kauff, Susan M Domchek. J Natl Cancer Inst 2009
Timothy R Rebbeck, Noah D Kauff, Susan M Domchek. J Natl Cancer Inst 2009
8
Knowledge, attitudes, and utilization of BRCA1/2 testing among women with early-onset breast cancer.
Nikki Peters, Susan M Domchek, Abigail Rose, Rachael Polis, Jill Stopfer, Katrina Armstrong. Genet Test 2005
Nikki Peters, Susan M Domchek, Abigail Rose, Rachael Polis, Jill Stopfer, Katrina Armstrong. Genet Test 2005
10
The role of financial factors in acceptance of clinical BRCA genetic testing.
Shannon Kieran, Lois J Loescher, Kyung Hee Lim. Genet Test 2007
Shannon Kieran, Lois J Loescher, Kyung Hee Lim. Genet Test 2007
12
Factors influencing patients' decisions to decline cancer genetic counseling services.
K P Geer, M E Ropka, W F Cohn, S M Jones, S Miesfeldt. J Genet Couns 2001
K P Geer, M E Ropka, W F Cohn, S M Jones, S Miesfeldt. J Genet Couns 2001
8
Clinicopathologic features of BRCA-linked and sporadic ovarian cancer.
J Boyd, Y Sonoda, M G Federici, F Bogomolniy, E Rhei, D L Maresco, P E Saigo, L A Almadrones, R R Barakat, C L Brown,[...]. JAMA 2000
J Boyd, Y Sonoda, M G Federici, F Bogomolniy, E Rhei, D L Maresco, P E Saigo, L A Almadrones, R R Barakat, C L Brown,[...]. JAMA 2000
8
Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
8
Psychosocial factors associated with the public's willingness to pay for genetic testing for cancer risk: a structural equations model.
K Bosompra, T Ashikaga, B S Flynn, J K Worden, L J Solomon. Health Educ Res 2001
K Bosompra, T Ashikaga, B S Flynn, J K Worden, L J Solomon. Health Educ Res 2001
10
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
8
Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.
Heather Hampel, Wendy Frankel, Jenny Panescu, Janet Lockman, Kaisa Sotamaa, Daniel Fix, Ilene Comeras, Jennifer La Jeunesse, Hidewaki Nakagawa, Judith A Westman,[...]. Cancer Res 2006
Heather Hampel, Wendy Frankel, Jenny Panescu, Janet Lockman, Kaisa Sotamaa, Daniel Fix, Ilene Comeras, Jennifer La Jeunesse, Hidewaki Nakagawa, Judith A Westman,[...]. Cancer Res 2006
8
Barriers to the use of genetic testing: a study of racial and ethnic disparities.
Sandra Suther, Gebre-Egziabher Kiros. Genet Med 2009
Sandra Suther, Gebre-Egziabher Kiros. Genet Med 2009
8
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.